Zacks Research Has Pessimistic Outlook of CLB Q3 Earnings

Core Laboratories Inc. (NYSE:CLB) – Stock analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for Core Laboratories in a note issued to investors on Friday, January 17th. Zacks Research analyst T. Saha now forecasts that the oil and gas company will post earnings of $0.27 per share for the quarter, down from their prior forecast of $0.28. The consensus estimate for Core Laboratories’ current full-year earnings is $0.80 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.24 EPS and Q3 2026 earnings at $0.32 EPS.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.04. The business had revenue of $134.40 million during the quarter, compared to the consensus estimate of $134.16 million. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. Core Laboratories’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.22 earnings per share.

Other research analysts also recently issued research reports about the company. Citigroup lowered their target price on Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a research note on Thursday, October 31st. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $17.00.

Core Laboratories Stock Up 3.4 %

Shares of NYSE CLB opened at $20.36 on Monday. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55. The company has a market cap of $956.09 million, a price-to-earnings ratio of 31.33, a PEG ratio of 1.12 and a beta of 2.39. Core Laboratories has a 12 month low of $13.82 and a 12 month high of $25.13. The stock has a 50-day moving average price of $19.09 and a two-hundred day moving average price of $19.56.

Hedge Funds Weigh In On Core Laboratories

A number of institutional investors and hedge funds have recently modified their holdings of CLB. Nisa Investment Advisors LLC lifted its holdings in shares of Core Laboratories by 2,688.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock worth $42,000 after purchasing an additional 2,339 shares in the last quarter. Ridgewood Investments LLC lifted its holdings in shares of Core Laboratories by 4.6% in the 4th quarter. Ridgewood Investments LLC now owns 32,612 shares of the oil and gas company’s stock worth $565,000 after purchasing an additional 1,428 shares in the last quarter. Confluence Investment Management LLC lifted its holdings in shares of Core Laboratories by 0.4% in the 4th quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company’s stock worth $2,360,000 after purchasing an additional 599 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Core Laboratories by 5.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 41,281 shares of the oil and gas company’s stock worth $765,000 after purchasing an additional 2,267 shares in the last quarter. Finally, Tidal Investments LLC lifted its holdings in shares of Core Laboratories by 1.7% in the 3rd quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company’s stock worth $813,000 after purchasing an additional 716 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.